Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 12: 158-164, 1966;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maneche, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maneche, H. C.

Clinical Chemistry, Vol 12, 158-164, Copyright © 1966 by the American Association for Clinical Chemistry

Blood Pyruvate in Malignant Neoplastic Disorders

H. C. Maneche 1

1 Department of Pathology, Presbyterian Hospital, Denver, Colo.

A moderate and statistically significant elevation of blood pyruvate levels, determined by an enzymatic method, was found in 60 patients with various malignant neoplastic disorders as compared with 20 control subjects. Studied were 42 cases of metastatic carcinoma, including 14 in which there were hepatic metastases and 18 cases of leukemia and lymphoma. No significant statistical difference was found when the values for the patients with malignant disease were compared with those found for a group of patients with non-neoplastic liver disorders.

Submitted on June 22, 1965
Accepted on November 4, 1965






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1966 by the American Association for Clinical Chemistry.